Wolf Group Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-25,436
| Closed | -$1.22M | – | 84 |
|
|
2018
Q4 | $1.22M | Buy |
25,436
+12
| +0% | +$573 | 0.9% | 37 |
|
|
2018
Q3 | $1.28M | Sell |
25,424
-1,788
| -7% | -$89.8K | 0.83% | 43 |
|
|
2018
Q2 | $1.37M | Buy |
27,212
+1,462
| +6% | +$73.7K | 0.89% | 48 |
|
|
2018
Q1 | $1.26M | Buy |
25,750
+4,091
| +19% | +$200K | 0.83% | 51 |
|
|
2017
Q4 | $960K | Sell |
21,659
-185
| -0.8% | -$8.2K | 0.6% | 64 |
|
|
2017
Q3 | $1.12M | Sell |
21,844
-9,883
| -31% | -$505K | 0.78% | 51 |
|
|
2017
Q2 | $1.71M | Sell |
31,727
-2,317
| -7% | -$125K | 1.31% | 32 |
|
|
2017
Q1 | $1.79M | Sell |
34,044
-3,013
| -8% | -$159K | 1.18% | 35 |
|
|
2016
Q4 | $1.78M | Sell |
37,057
-11,469
| -24% | -$552K | 1.2% | 34 |
|
|
2016
Q3 | $2.62M | Sell |
48,526
-9,507
| -16% | -$513K | 1.82% | 14 |
|
|
2016
Q2 | $3.14M | Buy |
58,033
+43
| +0.1% | +$2.33K | 2.32% | 6 |
|
|
2016
Q1 | $2.94M | Buy |
57,990
+8,419
| +17% | +$427K | 2.21% | 10 |
|
|
2015
Q4 | $2.5M | Buy |
+49,571
| New | +$2.5M | 1.86% | 11 |
|